The GRPEL2 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population generated by disrupting the GRPEL2 gene in the Jurkat immortalized human T-cell line. This polyclonal format encompasses a heterogeneous array of edited alleles, enabling immediate loss-of-function studies without single-cell-derived clones. The CRISPR/Cas9-mediated gene disruption provides a robust tool for examining the functional consequences of GRPEL2 ablation in T-cell biology and mitochondrial research.
Jurkat cells, clone E6-1, are a suspension-adapted human T-lymphocyte line derived from the peripheral blood of a 14-year-old male with acute T-lymphoblastic leukemia. They serve as a principal model for T-cell signaling, apoptosis, and HIV infection, and are extensively utilized for studying pathways linked to T-cell activation and metabolism. The Jurkat background is especially relevant for investigating mitochondrial processes, as T-cell receptor engagement triggers metabolic reprogramming dependent on mitochondrial function, thus providing a physiological context for GRPEL2 knockout studies.
GRPEL2 functions as a mitochondrial nucleotide exchange factor that catalyzes ADP release from mtHsp70 (HSPA9), the core chaperone of the TIM23 translocon, driving ATP-dependent import of precursor proteins into the matrix. It is regulated by mitochondrial stress signals through transcription factors such as NRF1, TFAM, and HSF1, and interacts with mtHsp70, DNAJA3, and MAGMAS. GRPEL2 disruption arrests mtHsp70??s ATPase cycle, causing precursor stalling on TIM23, activation of the mitochondrial unfolded protein response, and compromised proteostasis and respiratory chain assembly.
In Jurkat cells, GRPEL2 knockout is anticipated to disturb mitochondrial protein import and proteostasis, with potential impacts on T-cell activation, apoptosis, and metabolic fitness. Leukemic T-cell lines frequently display altered mitochondrial dynamics, making this polyclonal knockout population valuable for studying how mitochondrial import defects influence oncogenic signaling and therapeutic sensitivity. The inherent heterogeneity of the polyclonal model mimics the diversity of clinical leukemic blast populations, facilitating translational research into mitochondrial vulnerabilities in T-cell malignancies.
This knockout model supports diverse applications: dissecting mitochondrial proteostasis in T-cell activation, screening for small-molecule modulators of the TIM23 import pathway, and modeling congenital sideroblastic anemia and neurodegeneration. Key assays include Western blotting, RT-qPCR, flow cytometry for mitochondrial mass and membrane potential, ATP bioluminescence assays, apoptosis assays, and mitochondrial import kinetics experiments. Co-immunoprecipitation enables direct analysis of GRPEL2?CmtHsp70 interactions. For additional inquiries, please contact Ascent Research.
